At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Matthias Löhr, MD, PhD, from Karolinska Institutet, Stockholm, Sweden, discusses the application of next-generation sequencing for guiding cancer treatment decision-making.
Next-generation sequencing to guide treatment decision-making
14th June 2016
Oncology
Rate this content's potential impact on patient outcomes
Thank you!
Please share some more information on the rating you have given